Your browser doesn't support javascript.
loading
Introduction to pharmacogenetics.
McDermott, John Henry; Newman, William.
Affiliation
  • McDermott JH; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK john.mcdermott@mft.nhs.uk.
  • Newman W; Division of Evolution, Infection and Genomics, School of Biological Sciences, The University of Manchester, Manchester, UK.
Drug Ther Bull ; 61(11): 168-172, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37788890
ABSTRACT
There is considerable interindividual variability in the effectiveness and safety of medicines. Although the reasons for this are multifactorial, it is well recognised that genetic changes impacting the absorption or metabolism of these drugs play a significant contributory role. Understanding how these pharmacogenetic variants impact response to medicines, and leveraging this knowledge to guide prescribing, could have significant benefits for patients and health services. This article provides an introduction to the field of pharmacogenetics, including its nomenclature, the existing evidence base and the current state of implementation globally. We discuss the challenges in translating pharmacogenetic research into clinical practice and highlight the considerable benefits which can emerge in those health services where implementation is successful.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics Limits: Humans Language: En Journal: Drug Ther Bull Year: 2023 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics Limits: Humans Language: En Journal: Drug Ther Bull Year: 2023 Document type: Article Affiliation country: Reino Unido